284 related articles for article (PubMed ID: 14708972)
21. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.
Alam NA; Rowan AJ; Wortham NC; Pollard PJ; Mitchell M; Tyrer JP; Barclay E; Calonje E; Manek S; Adams SJ; Bowers PW; Burrows NP; Charles-Holmes R; Cook LJ; Daly BM; Ford GP; Fuller LC; Hadfield-Jones SE; Hardwick N; Highet AS; Keefe M; MacDonald-Hull SP; Potts ED; Crone M; Wilkinson S; Camacho-Martinez F; Jablonska S; Ratnavel R; MacDonald A; Mann RJ; Grice K; Guillet G; Lewis-Jones MS; McGrath H; Seukeran DC; Morrison PJ; Fleming S; Rahman S; Kelsell D; Leigh I; Olpin S; Tomlinson IP
Hum Mol Genet; 2003 Jun; 12(11):1241-52. PubMed ID: 12761039
[TBL] [Abstract][Full Text] [Related]
22. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson IP; Alam NA; Rowan AJ; Barclay E; Jaeger EE; Kelsell D; Leigh I; Gorman P; Lamlum H; Rahman S; Roylance RR; Olpin S; Bevan S; Barker K; Hearle N; Houlston RS; Kiuru M; Lehtonen R; Karhu A; Vilkki S; Laiho P; Eklund C; Vierimaa O; Aittomäki K; Hietala M; Sistonen P; Paetau A; Salovaara R; Herva R; Launonen V; Aaltonen LA;
Nat Genet; 2002 Apr; 30(4):406-10. PubMed ID: 11865300
[TBL] [Abstract][Full Text] [Related]
23. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
24. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E
Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
26. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
[TBL] [Abstract][Full Text] [Related]
27. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.
Sulkowski PL; Sundaram RK; Oeck S; Corso CD; Liu Y; Noorbakhsh S; Niger M; Boeke M; Ueno D; Kalathil AN; Bao X; Li J; Shuch B; Bindra RS; Glazer PM
Nat Genet; 2018 Aug; 50(8):1086-1092. PubMed ID: 30013182
[TBL] [Abstract][Full Text] [Related]
28. Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity.
Azzimato V; Chen P; Barreby E; Morgantini C; Levi L; Vankova A; Jager J; Sulen A; Diotallevi M; Shen JX; Miller A; Ellis E; Rydén M; Näslund E; Thorell A; Lauschke VM; Channon KM; Crabtree MJ; Haschemi A; Craige SM; Mori M; Spallotta F; Aouadi M
Gastroenterology; 2021 Dec; 161(6):1982-1997.e11. PubMed ID: 34425095
[TBL] [Abstract][Full Text] [Related]
29. Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Ueno D; Vasquez JC; Sule A; Liang J; van Doorn J; Sundaram R; Friedman S; Caliliw R; Ohtake S; Bao X; Li J; Ye H; Boyd K; Huang RR; Dodson J; Boutros P; Bindra RS; Shuch B
Oncotarget; 2022; 13():1054-1067. PubMed ID: 36128328
[TBL] [Abstract][Full Text] [Related]
30. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.
Vanharanta S; Pollard PJ; Lehtonen HJ; Laiho P; Sjöberg J; Leminen A; Aittomäki K; Arola J; Kruhoffer M; Orntoft TF; Tomlinson IP; Kiuru M; Arango D; Aaltonen LA
Hum Mol Genet; 2006 Jan; 15(1):97-103. PubMed ID: 16319128
[TBL] [Abstract][Full Text] [Related]
31. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation.
Brière JJ; Favier J; Gimenez-Roqueplo AP; Rustin P
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1114-20. PubMed ID: 16760265
[TBL] [Abstract][Full Text] [Related]
32. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
33. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T
J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213
[TBL] [Abstract][Full Text] [Related]
34. Fumarate hydratase gene mutation in two young patients with sporadic uterine fibroids.
Kubinova K; Tesarova M; Hansikova H; Vesela K; Kuzel D; Mara M
J Obstet Gynaecol Res; 2013 Jan; 39(1):410-4. PubMed ID: 22764886
[TBL] [Abstract][Full Text] [Related]
35. Fumarate hydratase in cancer: A multifaceted tumour suppressor.
Schmidt C; Sciacovelli M; Frezza C
Semin Cell Dev Biol; 2020 Feb; 98():15-25. PubMed ID: 31085323
[TBL] [Abstract][Full Text] [Related]
36. Direct and quantitative analysis of altered metabolic flux distributions and cellular ATP production pathway in fumarate hydratase-diminished cells.
Noguchi S; Ishikawa H; Wakita K; Matsuda F; Shimizu H
Sci Rep; 2020 Aug; 10(1):13065. PubMed ID: 32747645
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of cancer in patients with fumarate hydratase germline mutation.
Lehtonen HJ; Kiuru M; Ylisaukko-Oja SK; Salovaara R; Herva R; Koivisto PA; Vierimaa O; Aittomäki K; Pukkala E; Launonen V; Aaltonen LA
J Med Genet; 2006 Jun; 43(6):523-6. PubMed ID: 16155190
[TBL] [Abstract][Full Text] [Related]
38. Disruption of the TCA cycle reveals an ATF4-dependent integration of redox and amino acid metabolism.
Ryan DG; Yang M; Prag HA; Blanco GR; Nikitopoulou E; Segarra-Mondejar M; Powell CA; Young T; Burger N; Miljkovic JL; Minczuk M; Murphy MP; von Kriegsheim A; Frezza C
Elife; 2021 Dec; 10():. PubMed ID: 34939929
[TBL] [Abstract][Full Text] [Related]
39. No germline FH mutations in familial breast cancer patients.
Kiuru M; Lehtonen R; Eerola H; Aittomäki K; Blomqvist C; Nevanlinna H; Aaltonen LA; Launonen V
Eur J Hum Genet; 2005 Apr; 13(4):506-9. PubMed ID: 15523491
[TBL] [Abstract][Full Text] [Related]
40. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]